Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5339)
All Articles published online
|
Jul 28, 2007 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Worthley DL, Whitehall VL, Spring KJ, Leggett BA. Colorectal carcinogenesis: Road maps to cancer. World J Gastroenterol 2007; 13(28): 3784-3791 [PMID: 17657831 DOI: 10.3748/wjg.v13.i28.3784] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i28/3784.htm |
| Number | Citing Articles |
| 1 |
A Murata, Y Baba, M Watanabe, H Shigaki, K Miyake, T Ishimoto, M Iwatsuki, S Iwagami, Y Sakamoto, Y Miyamoto, N Yoshida, K Nosho, H Baba. Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer. British Journal of Cancer 2013; 109(2): 408 doi: 10.1038/bjc.2013.289
|
| 2 |
Sabha Rasool, Vamiq Rasool, Tahira Naqvi, Bashir A. Ganai, Bhahwal Ali Shah. Genetic unraveling of colorectal cancer. Tumor Biology 2014; 35(6): 5067 doi: 10.1007/s13277-014-1713-7
|
| 3 |
Pedro Pinto, Patrícia Rocha, Isabel Veiga, Joana Guedes, Manuela Pinheiro, Ana Peixoto, Carla Pinto, Maria Fragoso, Evaristo Sanches, António Araújo, Fernando Alves, Camila Coutinho, Paula Lopes, Rui Henrique, Manuel R. Teixeira. Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer. Cancer Genetics 2011; 204(8): 439 doi: 10.1016/j.cancergen.2011.07.003
|
| 4 |
|
| 5 |
Christine Koulis, Raymond Yap, Rebekah Engel, Thierry Jardé, Simon Wilkins, Gemma Solon, Jeremy D. Shapiro, Helen Abud, Paul McMurrick. Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer. Cancers 2020; 12(4): 812 doi: 10.3390/cancers12040812
|
| 6 |
Mouade El Bali, Joaira Bakkach, Mohcine Bennani Mechita, Alamgeer Yuchi. Colorectal Cancer: From Genetic Landscape to Targeted Therapy. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/9918116
|
| 7 |
Emily A Vucic, Carolyn J Brown, Wan L Lam. Epigenetics of cancer progression. Pharmacogenomics 2008; 9(2): 215 doi: 10.2217/14622416.9.2.215
|
| 8 |
Paulina Kober, Mateusz Bujko, Janusz Olędzki, Andrzej Tysarowski, Janusz A. Siedlecki. Methyl‐CpG binding column‐based identification of nine genes hypermethylated in colorectal cancer. Molecular Carcinogenesis 2011; 50(11): 846 doi: 10.1002/mc.20763
|
| 9 |
A. Naccarati, V. Polakova, B. Pardini, L. Vodickova, K. Hemminki, R. Kumar, P. Vodicka. Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. Mutagenesis 2012; 27(2): 211 doi: 10.1093/mutage/ger067
|
| 10 |
Li Guo, Guowei Yang, Yihao Kang, Sunjing Li, Rui Duan, Lulu Shen, Wenwen Jiang, Bowen Qian, Zibo Yin, Tingming Liang. Construction and Analysis of a ceRNA Network Reveals Potential Prognostic Markers in Colorectal Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00418
|
| 11 |
Albert K. Kwan, Caroline Y. Um, Robin E. Rutherford, March E. Seabrook, Elizabeth L. Barry, Veronika Fedirko, John A. Baron, Roberd M. Bostick. Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal‐appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial. Molecular Carcinogenesis 2019; 58(4): 511 doi: 10.1002/mc.22945
|
| 12 |
Xiao-na Chang, Fu-mei Shang, Hong-yu Jiang, Chen Chen, Zhe-yan Zhao, Sheng-he Deng, Jun Fan, Xiao-chuan Dong, Ming Yang, Yan Li, Kai-lin Cai, Li Liu, Hong-li Liu, Xiu Nie. Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China. Current Medical Science 2021; 41(1): 118 doi: 10.1007/s11596-021-2326-1
|
| 13 |
Maria Grazia Cerrito, Emanuela Grassilli. Identifying Novel Actionable Targets in Colon Cancer. Biomedicines 2021; 9(5): 579 doi: 10.3390/biomedicines9050579
|
| 14 |
Xing Chen, Zhu-Hong You, Gui-Ying Yan, Dun-Wei Gong. IRWRLDA: improved random walk with restart for lncRNA-disease association prediction. Oncotarget 2016; 7(36): 57919 doi: 10.18632/oncotarget.11141
|
| 15 |
María González-González, María Laura Gutiérrez, José María Sayagués, Luis Muñoz-Bellvís, Alberto Orfao. Genomic profiling of sporadic liver metastatic colorectal cancer. Seminars in Cancer Biology 2021; 71: 98 doi: 10.1016/j.semcancer.2020.05.013
|
| 16 |
Xiyun Deng, Yanna Cao, Yan Liu, Fazhi Li, Kamalanathan Sambandam, Srinivasan Rajaraman, Archibald S. Perkins, Alan P. Fields, Mark R. Hellmich, Courtney M. Townsend, E. Aubrey Thompson, Tien C. Ko. Overexpression of Evi‐1 oncoprotein represses TGF‐β signaling in colorectal cancer. Molecular Carcinogenesis 2013; 52(4): 255 doi: 10.1002/mc.21852
|
| 17 |
Hans Raskov, Hans-Christian Pommergaard, Jakob Burcharth, Jacob Rosenberg. Colorectal carcinogenesis-update and perspectives. World Journal of Gastroenterology 2014; 20(48): 18151-18164 doi: 10.3748/wjg.v20.i48.18151
|
| 18 |
Yanglin Zhu, Hong Qin, Kui Ye, Chenglu Sun, Yafei Qin, Guangming Li, Hongda Wang, Hao Wang. Dual role of IL-37 in the progression of tumors. Cytokine 2022; 150: 155760 doi: 10.1016/j.cyto.2021.155760
|
| 19 |
Jenia Jenab-Wolcott, Bruce Giantonio. Molecular Pathology of Neoplastic Gastrointestinal Diseases. Molecular Pathology Library 2013; 7: 141 doi: 10.1007/978-1-4614-6015-2_9
|
| 20 |
Eiji Sakai, Ken Ohata, Hideyuki Chiba, Nobuyuki Matsuhashi, Noriteru Doi, Junichi Fukushima, Hiroki Endo, Hirokazu Takahashi, Shingo Tsuji, Koichi Yagi, Keisuke Matsusaka, Hiroyuki Aburatani, Atsushi Nakajima, Atsushi Kaneda. Methylation epigenotypes and genetic features in colorectal laterally spreading tumors. International Journal of Cancer 2014; 135(7): 1586 doi: 10.1002/ijc.28814
|
| 21 |
Ramakrishna Vadde, Sridhar Radhakrishnan, Lavanya Reddivari, Jairam K. P. Vanamala. Triphala Extract Suppresses Proliferation and Induces Apoptosis in Human Colon Cancer Stem Cells via Suppressing c-Myc/Cyclin D1 and Elevation of Bax/Bcl-2 Ratio. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/649263
|
| 22 |
Stefania Marzinotto, Francesca Sessa, Alessandra Franzoni, Alessia Anselmi, Laura Rosa Gastaldo, Silvia Mason, Giuseppe Damante, Carlo Alberto Beltrami, Laura Mariuzzi. KRAS Codons 12 and 13 Mutation Analysis: A Comparative Study between Direct Sequencing and a New Sensitive Real-Time PCR Assay. Sequencing 2011; 2011: 1 doi: 10.1155/2011/895709
|
| 23 |
Xiao-Jing Luo, Qi Zhao, Jia Liu, Jia-Bo Zheng, Miao-Zhen Qiu, Huai-Qiang Ju, Rui-Hua Xu. Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer. Molecular Therapy 2021; 29(2): 587 doi: 10.1016/j.ymthe.2020.12.017
|
| 24 |
Veronika Polakova Vymetalkova, Jana Slyskova, Vlasta Korenkova, Ludovit Bielik, Lucie Langerova, Pavel Prochazka, Alexandra Rejhova, Lucie Schwarzova, Barbara Pardini, Alessio Naccarati, Pavel Vodicka. Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patients. BMC Medical Genetics 2014; 15(1) doi: 10.1186/1471-2350-15-17
|
| 25 |
Reetu Mukherji, John Marshall, Andreas Seeber. Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives. Cancers 2020; 12(8): 2001 doi: 10.3390/cancers12082001
|
| 26 |
Juan Carlos Herrera, Luis Fernando Isaza, José Luis Ramírez, Gonzalo Vásquez, Carlos Mario Muñetón. Detección de aneuploidías del cromosoma 17 y deleción del gen TP53 en una amplia variedad de tumores sólidos mediante hibridación in situ fluorescente bicolor. Biomédica 2010; 30(3): 390 doi: 10.7705/biomedica.v30i3.273
|
| 27 |
Jairam K. P. Vanamala, Aaron R. Massey, Srinivas Rao Pinnamaneni, Lavanya Reddivari, Kenneth F. Reardon. Grain and sweet sorghum (Sorghum bicolorL. Moench) serves as a novel source of bioactive compounds for human health. Critical Reviews in Food Science and Nutrition 2018; 58(17): 2867 doi: 10.1080/10408398.2017.1344186
|
| 28 |
Veronika Polakova Vymetalkova, Luca Vannucci, Vlasta Korenkova, Pavel Prochazka, Jana Slyskova, Ludmila Vodickova, Vendula Rusnakova, Ludovit Bielik, Monika Burocziova, Pavel Rossmann, Pavel Vodicka. Evaluation of tumor suppressor gene expressions and aberrant methylation in the colon of cancer-induced rats: a pilot study. Molecular Biology Reports 2013; 40(10): 5921 doi: 10.1007/s11033-013-2699-8
|
| 29 |
Aaron R. Massey, Lavanya Reddivari, Jairam Vanamala. The Dermal Layer of Sweet Sorghum (Sorghum bicolor) Stalk, a Byproduct of Biofuel Production and Source of Unique 3-Deoxyanthocyanidins, Has More Antiproliferative and Proapoptotic Activity than the Pith in p53 Variants of HCT116 and Colon Cancer Stem Cells. Journal of Agricultural and Food Chemistry 2014; 62(14): 3150 doi: 10.1021/jf405415u
|
| 30 |
Aaron R. Massey, Lavanya Reddivari, Sridhar Radhakrishnan, Venkata Charepalli, Eranda Karunathilake Kurundu Hewage, Vadde Ramakrishna, Jairam K.P. Vanamala. Pro-apoptotic activity against cancer stem cells differs between different parts of sweet sorghum. Journal of Functional Foods 2016; 23: 601 doi: 10.1016/j.jff.2016.03.004
|
| 31 |
Elsa N Garza-Treviño, Salvador L Said-Fernández, Herminia G Martínez-Rodríguez. Understanding the colon cancer stem cells and perspectives on treatment. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0163-7
|
| 32 |
Md Nur Alam, Muhammad Almoyad, Fazlul Huq. Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/4154185
|
| 33 |
Eduard Sidelnikov, Roberd M. Bostick, W. Dana Flanders, Qi Long, Veronika Fedirko, Aasma Shaukat, Carrie R. Daniel, Robin E. Rutherford. Effects of Calcium and Vitamin D on MLH1 and MSH2 Expression in Rectal Mucosa of Sporadic Colorectal Adenoma Patients. Cancer Epidemiology, Biomarkers & Prevention 2010; 19(4): 1022 doi: 10.1158/1055-9965.EPI-09-0526
|
| 34 |
Krittiya Korphaisarn, Ananya Pongpaibul, Chanin Limwongse, Ekkapong Roothumnong, Wipawi Klaisuban, Akarin Nimmannit, Artit Jinawath, Charuwan Akewanlop. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. World Journal of Gastroenterology 2015; 21(3): 926-934 doi: 10.3748/wjg.v21.i3.926
|
| 35 |
Carlos Humberto Afanador , Katherine Andrea Palacio , Luis Fernando Isaza , Enoc Ahumada , Carlos Mauricio Ocampo , Carlos Mario Muñetón. Caracterización molecular de pacientes con cáncer colorrectal. Biomédica 2022; 42(Sp. 1): 154 doi: 10.7705/biomedica.5957
|
| 36 |
Maoyu Li, Fang Peng, Guoqing Li, Yang Fu, Ying Huang, Zhuchu Chen, Yongheng Chen. Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis. Oncotarget 2016; 7(24): 37226 doi: 10.18632/oncotarget.9362
|
| 37 |
María Antonia Lizarbe, Jorge Calle-Espinosa, Eva Fernández-Lizarbe, Sara Fernández-Lizarbe, Miguel Ángel Robles, Nieves Olmo, Javier Turnay. Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/7354260
|
| 38 |
|
| 39 |
Jian Zhang, Tao Mao, Shuyun Wang, Dongsheng Wang, Zhaojian Niu, Zhenqing Sun, Jianli Zhang. Interleukin-35 expression is associated with colon cancer progression. Oncotarget 2017; 8(42): 71563 doi: 10.18632/oncotarget.17751
|
| 40 |
Ayda Pouyafar, Milad Zadi Heydarabad, Sina Bahar Aghdam, Majid Khaksar, Ako Azimi, Reza Rahbarghazi, Mehdi Talebi. Resveratrol potentially increased the tumoricidal effect of doxorubicin on SKOV3 cancer stem cells in vitro. Journal of Cellular Biochemistry 2019; 120(5): 8430 doi: 10.1002/jcb.28129
|
| 41 |
Manish Pratap Singh, Sandhya Rai, Ashutosh Pandey, Nand K. Singh, Sameer Srivastava. Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine. Genes & Diseases 2021; 8(2): 133 doi: 10.1016/j.gendis.2019.10.013
|
| 42 |
Ola Marzouk, John Schofield. Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer. Cancers 2011; 3(2): 2767 doi: 10.3390/cancers3022767
|
| 43 |
Adrienne C Paterson, Finlay A Macrae, Cathy Pizzey, Graham S Baldwin, Arthur Shulkes. Circulating gastrin concentrations in patients at increased risk of developing colorectal carcinoma. Journal of Gastroenterology and Hepatology 2014; 29(3): 480 doi: 10.1111/jgh.12417
|
| 44 |
Arjen H.G. Cleven, Sarah Derks, Muriel X.G. Draht, Kim M. Smits, Veerle Melotte, Leander Van Neste, Benjamin Tournier, Valerie Jooste, Caroline Chapusot, Matty P. Weijenberg, James G. Herman, Adriaan P. de Bruïne, Manon van Engeland.
CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer. Clinical Cancer Research 2014; 20(12): 3261 doi: 10.1158/1078-0432.CCR-12-3734
|
| 45 |
Raul D. Bernabe, Ronghua Zhao, Marcia R. Cruz-Correa. Coloproctology. 2010; : 1 doi: 10.1007/978-1-84882-756-1_1
|
| 46 |
Ben George, Scott Kopetz. Predictive and Prognostic Markers in Colorectal Cancer. Current Oncology Reports 2011; 13(3): 206 doi: 10.1007/s11912-011-0162-3
|
| 47 |
Lavanya Reddivari, Venkata Charepalli, Sridhar Radhakrishnan, Ramakrishna Vadde, Ryan J. Elias, Joshua D. Lambert, Jairam K. P. Vanamala. Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis. BMC Complementary and Alternative Medicine 2016; 16(1) doi: 10.1186/s12906-016-1254-2
|
| 48 |
Katharina Ilm, Wolfgang Kemmner, Marc Osterland, Susen Burock, Gudrun Koch, Pia Herrmann, Peter M Schlag, Ulrike Stein. High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0316-2
|
| 49 |
Joanna A. Gibson, Robert D. Odze. Pathology of premalignant colorectal neoplasia. Digestive Endoscopy 2016; 28(3): 312 doi: 10.1111/den.12633
|
| 50 |
Giridhar Mudduluru, Katharina Ilm, Mathias Dahlmann, Ulrike Stein. Mechanisms of Molecular Carcinogenesis – Volume 1. 2017; : 11 doi: 10.1007/978-3-319-53659-0_2
|
| 51 |
Myung-Kyu Jung, Ui Sup Shin, Young-Jun Ki, Yong-Bae Kim, Sun-Mi Moon, Se-Jin Sung. Is the Location of the Tumor Another Prognostic Factor for Patients With Colon Cancer?. Annals of Coloproctology 2017; 33(6): 210 doi: 10.3393/ac.2017.33.6.210
|
| 52 |
Xia Chu, Yiqi Xue, Xinying Huo, Jingsun Wei, Yuetong Chen, Rongbo Han, Hong Chen, Xinyu Su, Honghong Zhang, Yang Gong, Jinfei Chen. Establishment and characterization of a novel cell line (cc‑006cpm8) of moderately/poorly differentiated colorectal adenocarcinoma derived from a primary tumor of a patient. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4806
|
| 53 |
A. Benmoussa, S. Zamiati, W. Badre, A. Wakadi, N. Bennani, N. Tahiri Jouti, S. Nadifi. Colorectal cancer: Comparison of clinicopathologic features between Moroccans patients less than 50 years old and older. Pathologie Biologie 2013; 61(3): 117 doi: 10.1016/j.patbio.2012.01.003
|
| 54 |
S. Kansal, A. K. Negi, A. Bhatnagar, N. Agnihotri. Ras Signaling Pathway in the Chemopreventive Action of Different Ratios of Fish Oil and Corn Oil in Experimentally Induced Colon Carcinogenesis. Nutrition and Cancer 2012; 64(4): 559 doi: 10.1080/01635581.2012.675619
|
| 55 |
Avinash Gupta, Wasir Saka, David J Kerr. Personalized medicine in colorectal cancer: the evidence so far. Clinical Investigation 2012; 2(10): 1013 doi: 10.4155/cli.12.99
|
| 56 |
Xavier Sagaert. Prognostic biomarkers in colorectal cancer: where do we stand?. Virchows Archiv 2014; 464(3): 379 doi: 10.1007/s00428-013-1532-z
|
| 57 |
Emilio Gil‐Martín, Javier Egea, Russel J. Reiter, Alejandro Romero. The emergence of melatonin in oncology: Focus on colorectal cancer. Medicinal Research Reviews 2019; 39(6): 2239 doi: 10.1002/med.21582
|
| 58 |
Sandeep Kumar, Bhoomika Sharma, Priyanka Bhadwal, Prerna Sharma, Navneet Agnihotri. Therapeutic Foods. 2018; : 51 doi: 10.1016/B978-0-12-811517-6.00003-9
|
| 59 |
Tae Sung Ahn, Dongjun Jeong, Myoung Won Son, Haeil Jung, Soyoung Park, Hyungjoo Kim, Sang Byung Bae, Han Jo Kim, Young-Woo Jeon, Moon Soo Lee, Moo-Jun Baek. The BRAF mutation is associated with the prognosis in colorectal cancer. Journal of Cancer Research and Clinical Oncology 2014; 140(11): 1863 doi: 10.1007/s00432-014-1735-y
|
| 60 |
Chaar Ines, Ounissi Donia, Boughriba Rahma, Azza Ben Ammar, Amara Sameh, Taher Khalfallah, Ben hmida Abdelmajid, Mzabi Sabeh, Bouraoui Saadia. Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort. Tumor Biology 2014; 35(7): 7163 doi: 10.1007/s13277-014-1874-4
|
| 61 |
Qi Liao, Weiling He, Jianfa Liu, Yi Cen, Liang Luo, Chengliang Yu, Yang Li, Sitong Chen, Shiwei Duan. Identification and functional annotation of lncRNA genes with hypermethylation in colorectal cancer. Gene 2015; 572(2): 259 doi: 10.1016/j.gene.2015.07.028
|
| 62 |
M. Frattini, G. Gallino, S. Signoroni, D. Balestra, L. Lusa, L. Battaglia, G. Sozzi, L. Bertario, E. Leo, S. Pilotti, M.A. Pierotti. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer. Cancer Letters 2008; 263(2): 170 doi: 10.1016/j.canlet.2008.03.021
|
| 63 |
A. D. Roth, M. Delorenzi, S. Tejpar, P. Yan, D. Klingbiel, R. Fiocca, G. d'Ario, L. Cisar, R. Labianca, D. Cunningham, B. Nordlinger, F. Bosman, E. Van Cutsem. Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer. JNCI Journal of the National Cancer Institute 2012; 104(21): 1635 doi: 10.1093/jnci/djs427
|
| 64 |
|
| 65 |
Michał Skrzycki, Monika Majewska, Hanna Czeczot. Superoxide dismutase mRNA and protein level in human colorectal cancer. Open Life Sciences 2010; 5(5): 590 doi: 10.2478/s11535-010-0054-9
|
| 66 |
V. Krutovskikh, C. Partensky. Nouvelles perspectives en oncologie : épigénétique et cellules souches cancéreuses. Cancer/Radiothérapie 2011; 15(8): 716 doi: 10.1016/j.canrad.2011.05.012
|
| 67 |
Fang Peng, Ying Huang, Mao-Yu Li, Guo-Qing Li, Hui-Chao Huang, Rui Guan, Zhu-Chu Chen, Song-Ping Liang, Yong-Heng Chen. Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer. World Journal of Gastroenterology 2016; 22(18): 4515-4528 doi: 10.3748/wjg.v22.i18.4515
|
| 68 |
Haoran Bi, Yupeng Liu, Rui Pu, Tingting Xia, Hongru Sun, Hao Huang, Lei Zhang, Yuanyuan Zhang, Ying Liu, Jing Xu, Jiesheng Rong, Yashuang Zhao. CHST7 Gene Methylation and Sex-Specific Effects on Colorectal Cancer Risk. Digestive Diseases and Sciences 2019; 64(8): 2158 doi: 10.1007/s10620-019-05530-9
|
| 69 |
Nektaria Simiantonaki, Marios Taxeidis, Caren Jayasinghe, Ursula Kurzik-Dumke, Charles James Kirkpatrick. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer 2008; 8(1) doi: 10.1186/1471-2407-8-320
|
| 70 |
Syed Umesalma, Ganapasam Sudhandiran. Differential Inhibitory Effects of the Polyphenol Ellagic Acid on Inflammatory Mediators NF‐κB, iNOS, COX‐2, TNF‐α, and IL‐6 in 1,2‐Dimethylhydrazine‐Induced Rat Colon Carcinogenesis. Basic & Clinical Pharmacology & Toxicology 2010; 107(2): 650 doi: 10.1111/j.1742-7843.2010.00565.x
|
| 71 |
Shree G. Sharma, Margaret L. Gulley.
BRAF Mutation Testing in Colorectal Cancer. Archives of Pathology & Laboratory Medicine 2010; 134(8): 1225 doi: 10.5858/2009-0232-RS.1
|
| 72 |
Vanessa Deschoolmeester, Marc Baay, Pol Specenier, Filip Lardon, Jan B. Vermorken. A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy. The Oncologist 2010; 15(7): 699 doi: 10.1634/theoncologist.2010-0025
|
| 73 |
Nagahide Matsubara. Epigenetic Regulation and Colorectal Cancer. Diseases of the Colon & Rectum 2012; 55(1): 96 doi: 10.1097/DCR.0b013e318233a1ef
|
| 74 |
n-3 PUFAs: an Elixir in Prevention of Colorectal Cancer. Current Colorectal Cancer Reports 2015; 11(3): 141 doi: 10.1007/s11888-015-0268-3
|
| 75 |
Y Liu, G L Borchert, A Surazynski, J M Phang. Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers. Oncogene 2008; 27(53): 6729 doi: 10.1038/onc.2008.322
|
| 76 |
Christophe M. Raynaud, Juana Hernandez, Frédérique P. Llorca, Paolo Nuciforo, Marie-Christine Mathieu, Frederic Commo, Suzette Delaloge, Laure Sabatier, Fabrice André, Jean-Charles Soria. DNA Damage Repair and Telomere Length in Normal Breast, Preneoplastic Lesions, and Invasive Cancer. American Journal of Clinical Oncology 2010; 33(4): 341 doi: 10.1097/COC.0b013e3181b0c4c2
|
| 77 |
Agnieszka B. Bialkowska, Yuhong Du, Haian Fu, Vincent W. Yang. Identification of novel small-molecule compounds that inhibit the proproliferative Krüppel-like factor 5 in colorectal cancer cells by high-throughput screening. Molecular Cancer Therapeutics 2009; 8(3): 563 doi: 10.1158/1535-7163.MCT-08-0767
|
| 78 |
Xiaofei Yan, Jian Zhao, Rui Zhang. Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression. Oncotarget 2017; 8(30): 49064 doi: 10.18632/oncotarget.17093
|
| 79 |
Arnaud D. Roth, Sabine Tejpar, Mauro Delorenzi, Pu Yan, Roberto Fiocca, Dirk Klingbiel, Daniel Dietrich, Bart Biesmans, György Bodoky, Carlo Barone, Enrique Aranda, Bernard Nordlinger, Laura Cisar, Roberto Labianca, David Cunningham, Eric Van Cutsem, Fred Bosman. Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial. Journal of Clinical Oncology 2010; 28(3): 466 doi: 10.1200/JCO.2009.23.3452
|
| 80 |
Sabine Tejpar, Monica Bertagnolli, Fred Bosman, Heinz-Joseph Lenz, Levi Garraway, Frederic Waldman, Robert Warren, Andrea Bild, Denise Collins-Brennan, Hejin Hahn, D. Paul Harkin, Richard Kennedy, Mohammad Ilyas, Hans Morreau, Vitali Proutski, Charles Swanton, Ian Tomlinson, Mauro Delorenzi, Roberto Fiocca, Eric Van Cutsem, Arnaud Roth. Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery. The Oncologist 2010; 15(4): 390 doi: 10.1634/theoncologist.2009-0233
|
| 81 |
Peizhuang Zhao, Jiajia Ning, Jun Huang, Binqian Wei, Zhen Wang, Xue Huang. High Expression of MORC2 is Associated with Poor Clinical Outcomes and Immune Infiltrates in Colon Adenocarcinoma. International Journal of General Medicine 2023; : 4595 doi: 10.2147/IJGM.S420715
|
| 82 |
Talha Bader, Abdelsalam Ismail. Higher prevalence of KRAS mutations in colorectal cancer in Saudi Arabia: Propensity for lung metastasis. Alexandria Journal of Medicine 2014; 50(3): 203 doi: 10.1016/j.ajme.2014.01.003
|
| 83 |
Adam I. Cygankiewicz, Damian Jacenik, Wanda M. Krajewska. Introduction to Gastrointestinal Diseases Vol. 2. 2017; : 105 doi: 10.1007/978-3-319-59885-7_11
|
| 84 |
E. Tulupova, R. Kumar, M. Hanova, J. Slyskova, B. Pardini, V. Polakova, A. Naccarati, L. Vodickova, J. Novotny, J. Halamkova, K. Hemminki, P. Vodicka. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2008; 648(1-2): 40 doi: 10.1016/j.mrfmmm.2008.09.005
|
| 85 |
A S Strimpakos, K N Syrigos, M W Saif. Pharmacogenetics and biomarkers in colorectal cancer. The Pharmacogenomics Journal 2009; 9(3): 147 doi: 10.1038/tpj.2009.8
|
| 86 |
Vid Mlakar, Gašper Berginc, Metka Volavšek, Zdravko Štor, Miran Rems, Damjan Glavač. Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-282
|
| 87 |
Deeksha Rikhari, Ankit Srivastava, Sameer Srivastava. Nature-Inspired Intelligent Computing Techniques in Bioinformatics. Studies in Computational Intelligence 2023; 1066: 63 doi: 10.1007/978-981-19-6379-7_4
|
| 88 |
Raju Suresh Kumar, Abdulrahman I. Almansour, Natarajan Arumugam. In vitro mechanistic investigation of polycyclic cage-like heterocyclic hybrid possessing diverse pharmacophoric units. Journal of King Saud University - Science 2020; 32(4): 2406 doi: 10.1016/j.jksus.2020.03.029
|
| 89 |
Samer Alzoubi, Leigh Brody, Sunniyat Rahman, Anne-Laure Mahul-Mellier, Nicolas Mercado, Kazuhiro Ito, Mona El-Bahrawy, Andrew Silver, Alan Boobis, Jimmy D. Bell, Nabil Hajji. Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer. Oncotarget 2016; 7(28): 44505 doi: 10.18632/oncotarget.9887
|